 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
Is There a Role for PGx Strategies in Bundled Reimbursement Model for Cancer Treatment?
May 30, 2012
Is There a Role for PGx Strategies in Bundled Reimbursement Model for Cancer Treatment?
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- In Gene Patent Ruling, SCOTUS Draws Line Between Product of Nature and Invention
June 19, 2013 / Pharmacogenomics Reporter - Innovation Boom or Bust? Industry Gauges Impact of SCOTUS Ruling on Gene Patents
June 19, 2013 / Pharmacogenomics Reporter - With New BRCA Testing Options, Patient Groups Advise Women to Speak to Genetics Expert, Share Reports
June 19, 2013 / Pharmacogenomics Reporter - People in the News: Mike Stratton, Kimberly Popovits, Felix Baker, Julian Baker, and More
June 19, 2013 / Pharmacogenomics Reporter - Sanofi, Curie Institute Collaborate on Sequencing-based Ovarian Cancer
June 19, 2013 / GenomeWeb Daily News